Division of Pediatric Infectious Diseases Archives
Study to evaluate nasal flu vaccine for children
Jul. 28, 2022—Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.
Teen shares his battle with MIS-C following COVID-19 infection
Mar. 7, 2022—Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.
VUMC awarded CDC funding to combat antimicrobial resistance, infectious diseases
Dec. 7, 2021—Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).
Study explores impact of COVID-19 on children
Oct. 21, 2021— by Jessica Pasley In a large, prospective study of children with COVID-19 infection at Monroe Carell Jr. Children’s Hospital at Vanderbilt, researchers found that most children experienced brief and mild illness with a small minority requiring hospitalization. During the onset of the pandemic, medical teams were not sure how the infection would impact children....
Monroe Carell Jr. Children’s Hospital at Vanderbilt sees surge in rare MIS-C cases amid drop in COVID-19 numbers
Feb. 8, 2021—While the number of COVID-19 cases across the country is decreasing, pediatricians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are beginning to see a new post-surge trend: an increase in cases of multi-system inflammatory syndrome in children (MIS-C).
VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial
Jul. 14, 2020—An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.
